Lotus Eye Hospital Live Share Price Today, Share Analysis and Chart

Name: Lotus Eye Hospital and Institute Ltd.: Is Infosys Ltd. worth buying?
Item: Lotus Eye Hospital and Institute Ltd.
Rating: 2.568166625
Author: Trendlyne DVM scores

Expensive Performer

Iran war impact

Based on the analysis of Lotus Eye Hospital and Institute Ltd.\'s (LOTUSEYE) financial and operational data for the fiscal year 2025 and early 2026, the impact of the geopolitical conflict in the Middle East is evaluated as follows: ##### Overall Imp...

107.48 -1.38 (-1.27%)

26.88% Fall from 52W High

3,013

NSE+BSE Volume

NSE 10 Apr, 2026 3:46 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Expensive Valuation

- / 100

Technically Neutral

47.1 / 100

Expensive Performer These stocks are strong in quality but with mid-range technicals. Their valuations are expensive View Similar Embed DVM

No estimates available

Lotus Eye Hospital Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Lotus Eye Hospital and Institute Ltd. worth buying?

29 Votes:

Buy 68.97%

Sell 13.79%

Hold 17.24%

Lotus Eye Hospital Live Share Price Today, Share Analysis and Chart

Based on the analysis of Lotus Eye Hospital and Institute Ltd.\'s (LOTUSEYE) financial and operational data for the fiscal year 2025 and early 2026, the impact of the geopolitical conflict in the Middle East is evaluated as follows: ##### Overall Imp...

26.88% Fall from 52W High

SWOT Analysis

Lotus Eye Hospital Live Price Chart